PT-141 serves as a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound operates by activating specific receptors across the body, causing to augmented sexual function. Clinical studies have suggested that PT-141 could remarkably manage a spectrum of sexual dysfunctions in bot